We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 498

Canada: Preparing for change - 29 April 2016
  • Bereskin & Parr LLP
  • Canada
  • April 29 2016

The effects that the amendments to the Trademarks Act in Bill C-31 have on rights holders will be wide ranging, but the expanded definition of


Take Two Pills and Call Your Lawyer in the Morning: Consumers Allege They Were Misled by the Makers of COLD-FX
  • Bereskin & Parr LLP
  • Canada
  • April 5 2016

The makers of COLD-FX might be feeling a little under the weather after appearing in the BC Superior Court to further respond to allegations that


The Québec 2016-2017 Budget introduces an Innovative Companies Deduction
  • Bereskin & Parr LLP
  • Canada
  • March 22 2016

Last week’s announcement of Québec’s 2016-2017 Budget included an exciting new tax relief initiative for qualifying innovative Québec manufacturing


Supreme Court Promises to Review Contentious Patent Matter
  • Bereskin & Parr LLP
  • Canada
  • March 14 2016

At long last, the Supreme Court of Canada will hear a case involving the promise of the patent. The promise of the patent is a judge-made doctrine in


Utility - The Heightened Disclosure Pendulum Swings Again
  • Bereskin & Parr LLP
  • Canada
  • March 14 2016

The Federal Court of Canada has once again waivered on what is required in order to satisfy utility based on sound prediction. In Eli Lilly Canada


What Canadian Companies Need to Know about Upcoming Changes to The European Trademark System
  • Bereskin & Parr LLP
  • Canada, European Union
  • March 11 2016

On March 23, 2016, a new European Trademark Regulation will come into force. Along with a change of name of the Office for Harmonisation in the


Leave to Appeal to SCC: AstraZeneca Canada Inc et al v Apotex Inc et al (FCCA)
  • Bereskin & Parr LLP
  • Canada
  • March 10 2016

On March 10, 2016, the Supreme Court of Canada granted AstraZeneca Canada Inc.'s ("AstraZeneca") application for leave to appeal from the decision of


New Funding Programs are Putting the "Green" into Green Technology
  • Bereskin & Parr LLP
  • Canada
  • March 10 2016

Ontario Cleantech companies are receiving some key ingredients from various programs to help them grow their technology and compete on the world


Gene Patents Remain Valid in Canada
  • Bereskin & Parr LLP
  • Canada
  • March 10 2016

The case involving a Children’s Hospital of Eastern Ontario (“CHEO”) challenge to an isolated gene patent has settled. For background on the case and


Leave to Appeal to SCC: Google Inc v Equustek Solutions Inc (BCCA)
  • Bereskin & Parr LLP
  • Canada
  • March 7 2016

On February 18, 2016, the Supreme Court of Canada granted Google Inc's ("Google") application for leave to appeal from the British Columbia Court of